Bayer Aktiengesellschaft (FRA:BAYN)
Germany · Delayed Price · Currency is EUR 30.24
-0.32 (-1.05%)
At close: Dec 1, 2025
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 91,864 employees as of December 31, 2024. The number of employees decreased by 5,067 or -5.23% compared to the previous year.
Employees
91,864
Change (1Y)
-5,067
Growth (1Y)
-5.23%
Revenue / Employee
€518,248
Profits / Employee
€2,237
Market Cap
29.93B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Dec 31, 2021 | 95,950 | -5 | -0.01% |
| Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Bayer Aktiengesellschaft News
- 5 hours ago - Trump administration backs Bayer's bid to curb Roundup lawsuits - Reuters
- 6 hours ago - Bayer Welcomes Solicitor General Support for U.S. Supreme Court Review - Business Wire
- 13 hours ago - Bayer’s MEDRAD Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations - Wallstreet:Online
- 13 hours ago - Bayer's MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations - Business Wire
- 15 hours ago - Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Value Stock - Nasdaq
- 16 hours ago - Dare Bioscience (DARE) Regains Ovaprene Rights from Bayer - GuruFocus
- 7 days ago - BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study - Nasdaq
- 7 days ago - Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study - Benzinga